社区贫困与儿童异基因造血细胞移植结局:CIBMTR分析
该研究利用CIBMTR数据库,纳入2006至2015年接受首次异基因HCT的≤18岁儿童,恶性病2053例、非恶性病1696例,以高贫困邮编(≥20%人口低于联邦贫困线)为暴露。非恶性病中社区贫困与任何HCT结局无关;恶性病中社区贫困增加TRM风险,但不影响OS或其他结局;恶性病中接受医疗补助保险者OS更差且TRM更高。
要点
- 非恶性病儿童中,社区贫困与HCT结局无关联。
- 恶性病儿童中,社区贫困增加TRM风险,但不影响OS。
- 恶性病儿童中,医疗补助保险与更差OS和更高TRM相关。
核心结论
- 儿童非恶性病HCT后,社区贫困与所评估的HCT结局无关。
- 儿童恶性病HCT后,社区贫困与TRM风险增加相关,但未发现与OS或其他移植结局的关联。
- 恶性病HCT儿童中,医疗补助保险与更差OS和更高TRM相关。
研究设计与样本
- 基于CIBMTR数据库的回顾性队列分析,纳入2006至2015年首次接受异基因HCT的≤18岁儿童。
- 恶性病队列2053例,非恶性病队列1696例。
- 社区贫困暴露按美国人口普查定义预设为居住在高贫困邮编(≥20%人口低于100%联邦贫困线)。
主要发现
- 非恶性病儿童中,社区贫困与任何HCT结局均无关联。
- 恶性病儿童中,社区贫困与TRM风险增加相关。
- 恶性病儿童中,社区贫困与OS或其他移植结局无关联。
- 恶性病儿童中,医疗补助保险者较私人保险者OS更差且TRM增加。
关键数值与推荐
- 高贫困邮编定义为≥20%人口低于100%联邦贫困线。
- 主要结局OS定义为从HCT至任何原因死亡的时间。
- 次要结局包括恶性病复发、TRM、急慢性GVHD及HCT后100天内感染。
临床怎么用
- 儿童恶性病HCT前评估可关注社区贫困及保险类型,以识别TRM高危人群。
- 医疗补助保险可作为恶性病HCT儿童不良结局的风险标志。
- 研究提示需进一步探索家庭层面贫困对HCT结局的影响以指导干预。
局限性
- 社区贫困为邮编层面暴露,非家庭层面贫困。
- 回顾性队列设计,可能存在未测量混杂。
- 恶性病中社区贫困与TRM的关联需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed to identify the association between neighborhood poverty and HCT outcomes for pediatric allogeneic HCT recipients in the Center for International Blood and Marrow Transplant Research database. We assembled 2 pediatric cohorts undergoing first allogeneic HCT from 2006 to 2015 at age ≤18 years, including 2053 children with malignant disease and 1696 children with nonmalignant disease. Neighborhood poverty exposure was defined a priori per the US Census definition as living in a high-poverty ZIP code (≥20% of persons below 100% federal poverty level) and used as the primary predictor in all analyses. Our primary outcome was overall survival (OS), defined as the time from HCT until death resulting from any cause. Secondary outcomes included relapse and transplantation-related mortality (TRM) in malignant disease, acute and chronic graft-versus-host disease, and infection in the first 100 days post-HCT. Among children undergoing transplantation for nonmalignant disease, neighborhood poverty was not associated with any HCT outcome. Among children undergoing transplantation for malignant disease, neighborhood poverty conferred an increased risk of TRM but was not associated with inferior OS or any other transplantation outcome. Among children with malignant disease, a key secondary finding was that children with Medicaid insurance experienced inferior OS and increased TRM compared with those with private insurance. These data suggest opportunities for future investigation of the effects of household-level poverty exposure on HCT outcomes in pediatric malignant disease to inform care delivery interventions.
引用
- Bona K, Brazauskas R, He N, et al. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Blood. 2021. PMID: 33104215. doi:10.1182/blood.2020006252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。